CN103103293A - 登革2型病毒纳米磁分离实时荧光定量pcr检测试剂盒及核苷酸序列 - Google Patents
登革2型病毒纳米磁分离实时荧光定量pcr检测试剂盒及核苷酸序列 Download PDFInfo
- Publication number
- CN103103293A CN103103293A CN2013100414125A CN201310041412A CN103103293A CN 103103293 A CN103103293 A CN 103103293A CN 2013100414125 A CN2013100414125 A CN 2013100414125A CN 201310041412 A CN201310041412 A CN 201310041412A CN 103103293 A CN103103293 A CN 103103293A
- Authority
- CN
- China
- Prior art keywords
- dengue
- real
- sequence
- time fluorescence
- quantitative pcr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003753 real-time PCR Methods 0.000 title claims abstract description 34
- 238000012360 testing method Methods 0.000 title claims abstract description 15
- 239000002773 nucleotide Substances 0.000 title claims abstract description 13
- 125000003729 nucleotide group Chemical group 0.000 title claims abstract description 13
- 238000007885 magnetic separation Methods 0.000 title claims abstract description 8
- 241000710815 Dengue virus 2 Species 0.000 title abstract 3
- 238000003752 polymerase chain reaction Methods 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 claims abstract description 41
- 239000002105 nanoparticle Substances 0.000 claims abstract description 9
- 241000700605 Viruses Species 0.000 claims description 66
- 206010012310 Dengue fever Diseases 0.000 claims description 65
- 208000025729 dengue disease Diseases 0.000 claims description 56
- 208000001490 Dengue Diseases 0.000 claims description 50
- 239000013612 plasmid Substances 0.000 claims description 39
- 238000006243 chemical reaction Methods 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 27
- 208000009714 Severe Dengue Diseases 0.000 claims description 25
- 238000010839 reverse transcription Methods 0.000 claims description 23
- 238000011144 upstream manufacturing Methods 0.000 claims description 21
- 239000007850 fluorescent dye Substances 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 239000013642 negative control Substances 0.000 claims description 19
- 239000006228 supernatant Substances 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 16
- 238000001179 sorption measurement Methods 0.000 claims description 16
- 239000013641 positive control Substances 0.000 claims description 15
- 210000002966 serum Anatomy 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 13
- 239000012295 chemical reaction liquid Substances 0.000 claims description 12
- 239000006166 lysate Substances 0.000 claims description 10
- 239000006249 magnetic particle Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 8
- 239000006210 lotion Substances 0.000 claims description 8
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 7
- 230000009849 deactivation Effects 0.000 claims description 7
- 229960004756 ethanol Drugs 0.000 claims description 7
- 210000002381 plasma Anatomy 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 5
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims description 4
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- 238000005979 thermal decomposition reaction Methods 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 125000005372 silanol group Chemical group 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 abstract description 12
- 229920002477 rna polymer Polymers 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000010419 fine particle Substances 0.000 abstract 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 abstract 2
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 32
- 241000725619 Dengue virus Species 0.000 description 24
- 108020004707 nucleic acids Proteins 0.000 description 15
- 102000039446 nucleic acids Human genes 0.000 description 15
- 150000007523 nucleic acids Chemical class 0.000 description 15
- 230000003321 amplification Effects 0.000 description 11
- 238000000605 extraction Methods 0.000 description 11
- 238000003199 nucleic acid amplification method Methods 0.000 description 11
- 238000000926 separation method Methods 0.000 description 10
- 230000003612 virological effect Effects 0.000 description 10
- 108020000999 Viral RNA Proteins 0.000 description 9
- 201000002950 dengue hemorrhagic fever Diseases 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000013461 design Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 239000007795 chemical reaction product Substances 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000013399 early diagnosis Methods 0.000 description 4
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000004445 quantitative analysis Methods 0.000 description 4
- 208000031504 Asymptomatic Infections Diseases 0.000 description 3
- 241000709721 Hepatovirus A Species 0.000 description 3
- 101710116435 Outer membrane protein Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 241000710772 Yellow fever virus Species 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 201000009892 dengue shock syndrome Diseases 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 229940051021 yellow-fever virus Drugs 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241000711549 Hepacivirus C Species 0.000 description 2
- 241000713869 Moloney murine leukemia virus Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 241001493065 dsRNA viruses Species 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- CDVAIHNNWWJFJW-UHFFFAOYSA-N 3,5-diethoxycarbonyl-1,4-dihydrocollidine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1C CDVAIHNNWWJFJW-UHFFFAOYSA-N 0.000 description 1
- 241000256118 Aedes aegypti Species 0.000 description 1
- 241000256173 Aedes albopictus Species 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101710204837 Envelope small membrane protein Proteins 0.000 description 1
- 241000710831 Flavivirus Species 0.000 description 1
- 241000001014 Gnathanodon speciosus Species 0.000 description 1
- 206010061192 Haemorrhagic fever Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 101710145006 Lysis protein Proteins 0.000 description 1
- 235000013862 Narcissus jonquilla Nutrition 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 238000012339 Real-time fluorescence quantitative polymerase chain reaction Methods 0.000 description 1
- 101710141795 Ribonuclease inhibitor Proteins 0.000 description 1
- 229940122208 Ribonuclease inhibitor Drugs 0.000 description 1
- 102100037968 Ribonuclease inhibitor Human genes 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 201000006449 West Nile encephalitis Diseases 0.000 description 1
- 206010057293 West Nile viral infection Diseases 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000002122 magnetic nanoparticle Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000001216 nucleic acid method Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000013615 primer Substances 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical class [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 208000037972 tropical disease Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310041412.5A CN103103293B (zh) | 2013-02-01 | 2013-02-01 | 登革2型病毒纳米磁分离实时荧光定量pcr检测试剂盒及核苷酸序列 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310041412.5A CN103103293B (zh) | 2013-02-01 | 2013-02-01 | 登革2型病毒纳米磁分离实时荧光定量pcr检测试剂盒及核苷酸序列 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103103293A true CN103103293A (zh) | 2013-05-15 |
CN103103293B CN103103293B (zh) | 2014-04-16 |
Family
ID=48311483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310041412.5A Expired - Fee Related CN103103293B (zh) | 2013-02-01 | 2013-02-01 | 登革2型病毒纳米磁分离实时荧光定量pcr检测试剂盒及核苷酸序列 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103103293B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111549181A (zh) * | 2020-05-20 | 2020-08-18 | 广西壮族自治区兽医研究所 | 一种检测禽腺病毒4型的纳米pcr方法、试剂盒及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1258317A (zh) * | 1996-11-25 | 2000-06-28 | 遗传工程与生物技术中心 | 登革病毒基因表达的方法 |
CN101308137A (zh) * | 2007-05-15 | 2008-11-19 | 广东省疾病预防控制中心 | 登革病毒IgG抗体酶联免疫诊断试剂盒 |
CN101343319A (zh) * | 2008-04-10 | 2009-01-14 | 中国人民解放军第三军医大学 | 抗登革病毒e蛋白的单克隆抗体、制备方法及其应用 |
CN102277447A (zh) * | 2011-05-27 | 2011-12-14 | 江苏硕世生物科技有限公司 | 登革热病毒ⅰ型/ⅱ型双重荧光pcr检测试剂盒 |
-
2013
- 2013-02-01 CN CN201310041412.5A patent/CN103103293B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1258317A (zh) * | 1996-11-25 | 2000-06-28 | 遗传工程与生物技术中心 | 登革病毒基因表达的方法 |
CN101308137A (zh) * | 2007-05-15 | 2008-11-19 | 广东省疾病预防控制中心 | 登革病毒IgG抗体酶联免疫诊断试剂盒 |
CN101343319A (zh) * | 2008-04-10 | 2009-01-14 | 中国人民解放军第三军医大学 | 抗登革病毒e蛋白的单克隆抗体、制备方法及其应用 |
CN102277447A (zh) * | 2011-05-27 | 2011-12-14 | 江苏硕世生物科技有限公司 | 登革热病毒ⅰ型/ⅱ型双重荧光pcr检测试剂盒 |
Non-Patent Citations (8)
Title |
---|
《Applied Microbiology and Biotechnology》 20061231 Sonja Berensmeier "Magnetic particles for the separation and purification of nucleic acids" 第73卷, 第3期 * |
《Nanotechnology》 20120328 A G Roca et.al. "Surface functionalization for tailoring the aggregation and magnetic behaviour of silica-coated iron oxide nanostructures" 第23卷, 第15期 * |
《中国媒介生物学及控制杂志》 20061231 徐昌平等 "TaqMan荧光定量RT-PCR快速检测登革1、2型病毒" 第17卷, 第6期 * |
《分子诊断与治疗杂志》 20120531 罗雅艳等 "登革病毒TaqMan MGB实时荧光定量PCR检测方法的建立及初步应用" 第4卷, 第3期 * |
A G ROCA ET.AL.: ""Surface functionalization for tailoring the aggregation and magnetic behaviour of silica-coated iron oxide nanostructures"", 《NANOTECHNOLOGY》 * |
SONJA BERENSMEIER: ""Magnetic particles for the separation and purification of nucleic acids"", 《APPLIED MICROBIOLOGY AND BIOTECHNOLOGY》 * |
徐昌平等: ""TaqMan荧光定量RT-PCR快速检测登革1、2型病毒"", 《中国媒介生物学及控制杂志》 * |
罗雅艳等: ""登革病毒TaqMan MGB实时荧光定量PCR检测方法的建立及初步应用"", 《分子诊断与治疗杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111549181A (zh) * | 2020-05-20 | 2020-08-18 | 广西壮族自治区兽医研究所 | 一种检测禽腺病毒4型的纳米pcr方法、试剂盒及应用 |
CN111549181B (zh) * | 2020-05-20 | 2023-08-25 | 广西壮族自治区兽医研究所 | 一种检测禽腺病毒4型的纳米pcr方法、试剂盒及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103103293B (zh) | 2014-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106367533B (zh) | 用于检测寨卡病毒的核酸、实时荧光rpa试剂盒及方法 | |
CN107151711A (zh) | 一种检测登革病毒和寨卡病毒的双重荧光定量rt‑pcr试剂盒 | |
CN107557493B (zh) | 一种肠道病毒分型检测试剂盒 | |
CN110305985B (zh) | 一种利用三重实时荧光定量rt-pcr检测寨卡病毒、基孔肯雅病毒和马雅罗病毒的方法 | |
CN105734171A (zh) | 一种寨卡病毒荧光pcr检测试剂盒 | |
CN107513584A (zh) | 一种检测肠道病毒的五重荧光定量试剂盒 | |
Hu et al. | A one-step duplex rRT-PCR assay for the simultaneous detection of duck hepatitis A virus genotypes 1 and 3 | |
CN109402239A (zh) | 一种用于实时荧光定量pcr的免提取直接扩增试剂及其应用 | |
CN108330210A (zh) | 寨卡病毒、登革热病毒和基孔肯雅病毒核酸检测试剂盒及其用途 | |
CN101538619A (zh) | 一种戊型肝炎病毒rna检测试剂盒 | |
CN104711373A (zh) | 耐RNase的登革病毒核酸检测质控品的制备方法 | |
CN104561369A (zh) | 一种手足口病肠道病毒巢式pcr检测试剂盒及非诊断性分型方法 | |
CN103952496B (zh) | 一种检测猪传染性胃肠炎病毒与猪流行性腹泻病毒的二重pcr方法 | |
CN103484568B (zh) | 一种草鱼呼肠孤病毒ⅰ型和ⅱ型的双重荧光定量pcr检测方法及其试剂盒 | |
CN103103293B (zh) | 登革2型病毒纳米磁分离实时荧光定量pcr检测试剂盒及核苷酸序列 | |
CN106222305A (zh) | 一种蓝莓休克病毒分子检测试剂盒及其检测方法 | |
CN105420411A (zh) | 一种肠道病毒通用型、柯萨奇病毒a16型、肠道病毒71型核酸荧光pcr检测试剂盒 | |
CN101948936A (zh) | 一种检测水产品中诺如病毒的实时荧光pcr方法 | |
CN106119421A (zh) | 猪蓝耳病qyyz株的荧光定量检测引物、探针及试剂盒 | |
CN102605103B (zh) | 一种检测诺沃克病毒核苷酸的引物、探针及方法 | |
CN104073570B (zh) | 用于鉴定人类腺病毒55型的引物对、引物探针组合物以及它们的应用 | |
CN102154519A (zh) | 型通用登革病毒TaqMan实时荧光定量PCR检测试剂盒 | |
CN103215389B (zh) | 猪繁殖与呼吸综合症和猪乙型脑炎双重一步法rt-pcr诊断试剂盒 | |
CN109609697A (zh) | 一种基于raa荧光法快速检测人鼻病毒的引物、探针及检测试剂盒 | |
CN103014180A (zh) | 一种人星状病毒核苷酸的检测引物和探针及检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: STATE NANOMETER SCIENCE CENTER Effective date: 20140725 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140725 Address after: 100026 Beijing city Chaoyang District tianshuiyuan Street No. 6 Patentee after: BEIJING ENTRY-EXIT INSPECTION AND QUARANTINE BUREAU, P.R. CHINA Patentee after: NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY Address before: 100026 Beijing city Chaoyang District tianshuiyuan Street No. 6 Patentee before: BEIJING ENTRY-EXIT INSPECTION AND QUARANTINE BUREAU, P.R. CHINA |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140416 |
|
CF01 | Termination of patent right due to non-payment of annual fee |